Clinical Trial Update: Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating neoadjuvant cadonilimab plus perioperative oxaliplatin and S-1 for diffuse or mixed-type locally advanced gastric/GEJ adenocarcinoma; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Cadonilimab
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Zuoyi Jiao | Conditions: Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]), Neoadjuvant Therapy | Phase 3 | Status: RECRUITING